Differential developmental regulation of pancreasspecific genes has not been reported for the human fetal pancreas. We have therefore undertaken a systematic, quantitative analysis of the transcriptional levels of various genes in the human pancreas at different stages of fetal and postnatal development. Using sensitive ribonuclease protection assays, in situ hybridization, and the polymerase chain reaction, our results indicate the following: 1 ) Transcriptional levels of insulin and amylin remain lower in the fetal than in the adult pancreas, whereas glucagon and somatostatin mRNA levels are consistently greater after 14 wk gestation than postnatally. These results are in agreement with previous immunohistochemical studies of these gene products.
The developing human fetal pancreas has been the transcription of the endocrine genes occurred before desubject of many immunohistochemical and ultrastruc-tectable morphogenesis in the mouse. It was suggested tural studies. The appearance and frequency of the dif-that this "premorphogenetic phase" of organogenesis ferent endocrine cell types vary during development, and may represent the beginning of the endocrine cell linit is now generally accepted that the a-cells appear first at eages. A similar situation may also occur in the human approximately 8-9 wk gestation, followed sequentially by pancreas. the p-cells, &-cells7 and PP-cells-BY 9-10 wk gestation7
Insulin release from the pancreatic islets is controlled all four pancreatic endocrine cell populations have been by the uptake and metabolism of glucose by the p-cells. detected immunOfluOrescence, immunOcytOchemis-Although insulin is present in the human fetal pancreas try, and electron microscopy (1) (2) (3) (4) . from 10 wk gestation, insulin release remains practically Studies in systems, including the pan-unresponsive to glucose stimulation until birth (6). The cress, have shown that patterns gene expres-cellular uptake of glucose across the plasma membrane is sion can differ significantly from those detected by tech-accomplished by membrane-associated carrier proteins, niques that determine the presence protein-Using a termed glucose transporters. GLUT-1 is the predominant combination of embryo microdissection and the polymer-isoform expressed in most fetal tissues7 whereas GLUT-2 ase chain reaction, Gitte.5 and Rutter (5) observed that is the major isoform detected in adult pancreatic p-cells (7) (8) (9) . It has been suggested that the glucose-sensing creatic development; therefore, it was important to examine their expression levels in light of the reported glucose insensitivity of the fetal P-cell.
Since the identification of the reg gene in adult rat islets undergoing regeneration (1 I), its physiologic role has remained unclear, with evidence for both exocrine and endocrine involvement (12) (13) (14) (15) . Studies on the expression of the reg gene in the human fetal pancreas may help clarify its role in pancreatic development.
This study was undertaken to obtain a more complete understanding of pancreatic ontogeny as it relates to the transcriptional regulation of pancreatic genes. We present detailed quantitative data on the developmental regulation of the steady state levels of the mRNA encoding the islet hormones, as well as other pancreas-or isletspecific proteins in the human fetal and postnatal pancreas.
METHODS

T i procurement.
Intact human fetal pancreata at 12-24 wk gestational age were obtained through nonprofit organ procurement centers (Advanced Bioscience Resources, Oakland, CA; International Institute for the Advancement of Medicine, Exton, PA). Informed consent for tissue donation was obtained by the procurement centers. Gestational age was determined by several criteria, including biparietal diameter, femur length, and fetal foot measurements. Pancreatic tissues arrived in our laboratory after periods of 5 min and 24 h of warm and cold ischemia, respectively. Tissues were shipped on ice in RPMI 1640 medium (Iwine Scientific, Iwine, CA) containing 10% pooled normal human serum and antibiotics (100 U/mL penicillin, 0.1 mg/mL streptomycin, and 1 pg/mL amphotericin B). Upon arrival, pancreatic tissues were carefully dissected free of extraneous tissue, immediately snap-frozen in liquid nitrogen, and stored at -70°C. Adult pancreatic tissue was kindly provided by Dr. J. Chang (Immune Response Corp., Carlsbad, CA). Adult pancreas and liver RNA were obtained from Clontech Laboratories (Palo Alto, CA). A pancreatic section obtained at autopsy (4 h postmortem) of an 11-mo-old child who died of a brain tumor was provided by Children's Hospital of San Diego. Adult islets were kindly provided by Dr. C. Ricordi (University of Pittsburgh Transplant Institute, Pittsburgh, PA).
RNase protection assay probes. All probes used for the RNase protection assay were of human origin and were subcloned into the pGEM (Promega, Madison, WI) or pBluescript (Stratagene, La Jolla, CA) riboprobe vectors by standard procedures (16) . The insulin probe (provided by Dr. P. Miettinen, University of Helsinki, Finland) was a 262-bp fragment corresponding to amino acids 1-87 in preproinsulin mRNA (17) . The glucagon probe (provided by Dr. D. Drucker, Toronto General Hospital, Toronto, Ontario, Canada) encompassed 5'UTR sequences and amino acids 1-117 in preproglucagon mRNA (18) . Somatostatin (ATCC, Rockville, MD) was detected by a subclone representing bp 1245-1480 in the genomic sequence (19) . The cyclophilin probe (provided by Dr. D. Bergsma, SmithKline Beecham Pharmaceuticals, King of Prussia, PA) corresponded to S'UTR sequences and amino acids 1-28 in the full-length cDNA sequence (20) . Amylin was detected by a subclone representing a portion of the 5'UTR and amino acids 1-66 in the cDNA sequence (provided by Dr. D. Steiner, Howard Hughes Medical Institute, University of Chicago, Chicago, IL). The amylase probe (ATCC) was a genomic subclone composed of a portion of intron 1, the entire exon 1, and part of intron 2 (21) . The reg gene probe (provided by Dr. H. Okamoto, Tohoku University School of Medicine, Sendai, Japan) corresponded to amino acids 115-165 and 3'UTR sequences (11). The GLUT-1 probe (ATCC) consisted of 5'UTR sequences and amino acids 1-93 in the cDNA sequence (22) . Plasmid constructs were linearized with the appropriate restriction enzymes and gel purified using the QIAEX gel extraction kit (QIAGEN Inc., Chatsworth, CA). Radiolabeled antisense probes were generated by in vitro transcription in the presence of [32~]uridine triphosphate using the appropriate RNA polymerase (23) . Protected probe lengths are as follows: insulin, 262 nt; glucagon, 389 nt; somatostatin, 236 nt; cyclophilin, 135 nt; amylin, 267 nt; amylase, 214 nt; reg, 180 nt; and GLUT-1, 294 nt.
RNA isolation and analysis. Total cytoplasmic RNA was isolated by the acid guanidinium thiocyanate method (24) and quantitated spectrophotometrically. Transcriptional analyses were performed using a multiprobe RNase protection assay (23, 25) . Total RNA (0.4-5 pg) was hybridized for 18 h at 56°C with 32~-labeled antisense RNA probes in 40 mmol/L PIPES buffer (pH 6.4) containing 400 mmol/L NaCI, 1 mmol/L EDTA, and 80% formamide. Yeast tRNA (10 pg) was included as a negative control. Excess probe and nonhomologous RNA sequences were removed by RNase digestion (50 pg/mL RNase A and 50 U/mL RNase TI) in 10 mmol/L Tris-HCI (pH 7.5),300 mmol/L NaCl, and 5 mmol/L EDTA for 1 h at 30"C, followed by treatment with 200 &mL proteinase K in 2% SDS for 30 min at 37°C. Samples were extracted with phenol/chloroform, ethanol precipitated with 10 p.g of yeast tRNA as carrier, and dissolved in formamide sample buffer. The protected, doublestranded hybrids were separated by denaturing PAGE, followed by autoradiography on Kodak XRP film to visualize the target RNA. Quantitation was performed by scanning densitometry (LKB UltroScan XL Laser) and integrated using GelScan XL software (Pharmacia LKB, Piscataway, NJ). Peak heights were used to quantitate transcriptional levels. Different exposure times were used to ensure that all signals fell within the linear range of the densitometer. The probe-specific mRNA signals were normalized to the cyclophilin signal in each sample to account for differences in sample loading between lanes.
Tissue preparation for in situ hybridization and immunohistochemistry. A 24-wk gestational age fetal pancreas was fixed in 4% paraformaldehyde in PBS (pH 7.4) at 4°C for 4 h. After dehydration, the tissue was embedded in paraffin and 5-p,m sections were mounted on Superfrost/Plus slides (Fisher Scientific, Pittsburgh, PA). Consecutive sections were used for both in situ hybridization and immunohistochemistry.
In situ hybridization. Sense and antisense probes for both insulin and the reg gene were transcribed from cDNA in the presence of [35~]uridine triphosphate using the appropriate RNA polymerase. In situ hybridization was performed according to the method of Simmons et al. (26) . Tissue sections were digested with proteinase K (10 p,g/mL) for 30 min at 37"C, acetylated for 10 rnin at room temperature, rinsed in 0.3 mol/L NaCl-30 mmol/L sodium citrate (pH 7.0), dehydrated, and air dried. Hybridization with the 35~-labeled probes ( 2 4 x lo6 cpm/ mL) was performed at 55°C for 16 h in a buffer consisting of 50% formamide, 0.3 mol/L NaCI, 10 mmol/L Tris (pH 8.0), 1 mmol/L EDTA, l x Denhardt's solution (0.02% each of Ficoll400, polyvinylpyrrolidone, and BSA, Fraction V), 10% dextran sulfate, 50 mmol/L DTT, and 500 kglmL each of yeast tRNA and Torula yeast RNA. Sections were digested with RNase A at 37°C for 30 min, washed under high-stringency conditions, dehydrated in ethanol, and dried. Slides were coated with Kodak NTB-2 autoradiograph emulsion and exposed in sealed boxes at 4°C for 10 d. After development in Kodak D-19 for 3.5 min, the slides were rinsed, fixed, and counterstained with hematoxylin and eosin. Hybridization signals were analyzed using bright-and dark-field micros-COPYZmmunohistochemistry. Paraffin sections (5 pm) from the 24-wk gestational age fetal pancreas were stained for insulin using the immunoalkaline phosphatase technique (27) . Briefly, deparaffinized and rehydrated sections were blocked with 10% goat serum for 10 min, washed, and incubated with polyclonal guinea pig anti-porcine insulin antibody (Chemicon, El Segundo, CA) at a 1:100 dilution for 3 h. After washing, sections were incubated for 20 rnin with a biotinylated goat anti-rabbit antibody that crossreacts with guinea pig antibody (BioGenex, San Ramon, CA), washed, and incubated with streptavidin alkaline phosphatase for 20 min. Immunoreactivity was visualized using Fast Red (Sigma Chemical Co., St. Louis, MO) as chromogen, then sections were washed and counterstained with hematoxylin.
RT-PCR. Total RNA (1-2 pg) from fetal pancreatic tissues (13 wk gestation), adult islets, and adult liver was reverse transcribed into cDNA with an oligo d(T) primer according to manufacturer's recommendations (GeneAmp RNA PCR kit, Perkin-Elmer Cetus, Norwalk, CT). The samples were divided in two and amplified with GLUT-2 and glucokinase primers. Primers specific for human GLUT-2 and islet-specific glucokinase were as previously described (28) (29) (30) and were designed to span intron sequences to distinguish amplification products resulting from any contaminating genomic DNA sequences present in the RNA preparations. Amplifications were performed in a PowerBlock temperature cycler (Ericomp, San Diego, CA). Samples were initially denatured at 94OC for 1 min. Cycling parameters (45 cycles) were as follows: denaturation at 94°C for 1 min, annealing at 50°C for 1 min, and extension at 72°C for 1 rnin (GLUT-2), or annealing and extension simultaneously at 72°C for 1 rnin for glucokinase. A final extension at 72°C for 7 min was performed. Portions (10%) of the amplified products were analyzed by electrophoresis, in the presence of ethidium bromide, on 3% NuSieve GTG/l% agarose gels (FMC, Rockland, ME). 
RESULTS
Pancreatic hormone expression.
Transcriptional expression of the genes encoding insulin or glucagon ( Fig. 1) and somatostatin ( Fig. 2A) were examined in a series of human fetal pancreata, ranging in gestational ages from 12-24 wk, using a multiprobe RNase protection assay. Quantitation of the hormone-specific mRNA was performed by scanning densitometry, normalizing the probespecific hybridized signal to the signal from the ubiquitous housekeeping gene cyclophilin ( Table 1 ). The absence of any hybridized signals in the negative control (yeast tRNA) indicates the specificity of the assay. Insulin transcriptional levels continued to increase through gestation, with 3-to 5-fold more insulin mRNA present at 24 wk compared with 12 wk, yet remained lower than levels found in the adult pancreas (Table 1 ). In contrast, glucagon transcriptional levels peaked at approximately 20 wk gestational age and remained approximately 3-fold greater than adult levels. Somatostatin mRNA levels were consistently greater after 14 wk gestation than adult levels, which were barely detectable using equivalent RNA amounts (Table 1) .
Amylin and amylase gene expression. Because amylin is cosecreted with insulin in the adult pancreas in response to glucose, it was of interest to determine its expression pattern throughout fetal development. The levels of amylin transcripts were fairly constant, as opposed to the gradual increase in insulin transcripts, throughout the gestational ages examined. An amylin transcript was initially seen at 13 wk gestational age and did not vary considerably throughout development (Fig. 2B) . Amylin mRNA levels at 24 wk gestational age were approximately 10-fold lower than adult levels ( Table 1) . The pancreas from the 11-mo-old child had approximately 2-fold more amylin transcripts than the adult pancreas. No hybridization signal was seen in the negative control.
Amylase transcripts were not detectable in any of the fetal pancreata analyzed (data not shown). The adult pancreas had approximately 4-to 5-fold more amylase transcripts than the 11-mo-old pancreas ( Table 1) .
Expression of the reg gene. Transcriptional expression of the islet reg gene showed low expression levels before 16 wk gestation. At this time, however, a sudden increase in reg mRNA levels was seen and continued to increase through 24 wk gestational age, at which point it reached levels comparable to those in the adult pancreas (Fig. 2C,  Table I ), which were 2-fold greater than those in the 11-mo-old pancreas.
Consecutive serial sections (5 km thick) from a 24-wk gestational age pancreas were hybridized to the insulin and reg gene riboprobes to identify their locations within the fetal pancreas. In situ hybridization with the insulin probe was used to identify the p-cells. Silver grains were specifically associated with scattered clusters of epithelial cells of variable sizes throughout the acinar tissue (Fig. 3A) . Binding of the insulin sense probe showed very low background signals (Fig. 38) . The disseminated pattern of p-cells throughout the epithelial components of the fetal pancreas was also evident by immunostaining for insulin (Fig. 3C) . The reg gene signal was entirely localized within the acinar cells of the fetal pancreas (Fig.  3D-F) . The clustering of specific hybridization signals resembled the pattern seen with the insulin probe. However, the reg gene signal was clearly more abundant than the insulin signal. Mesenchymal tissue and ductal epithelium were devoid of the reg gene signal. Consecutive sections hybridized with the control sense probe showed only low levels of nonspecific hybridization signals (not shown). To determine whether the insulin and reg genes are both expressed in the p-cells, consecutive serial tissue sections were hybridized to both probes. We found no evidence for colocalization of the insulin (Fig. 4A-C ) and reg genes (Fig. 4D-F) . Glucose transporters and glucokinase expression. Expression of GLUT-1 transcripts in fetal pancreatic tissue was fairly constant through 16 wk gestational age, at which time an approximate 2-fold increase was measured ( Fig.  5 ; Table 1 ). The level of GLUT-1 transcripts at 18-24 wk gestation was similar to adult levels.
GLUT-2 transcripts were not detectable in any of the fetal or adult pancreata using the RNase protection assay, indicative of their low abundance in these tissues. Very low expression levels of glucokinase mRNA were detected in all the pancreatic samples analyzed, with no quantitative differences between fetal and adult tissues (data not shown). We therefore used the more sensitive technique, RT-PCR, to identify when transcription of these genes was first detectable (Fig. 6 ). Both GLUT-2 and the islet-specific glucokinase transcripts were detected using RT-PCR in the 13-wk fetal pancreata (n = 3), the youngest tissue samples tested. Human adult islets and liver were used as positive controls for GLUT-2. The specificity of the primers for the islet-specific glucokinase was borne out by the presence of an amplified product in the adult islet sample and the absence of any amplified product in the liver sample.
DISCUSSION
This study represents the first comprehensive report on comparative gene expression in the human fetal and postnatal pancreas, illustrating the developmental appearance and modulation of pancreas-specific genes. We used sensitive and highly specific RNase protection assays, in situ hybridization, and the polymerase chain reaction to detect and quantitate transcripts for endocrine and exocrine genes in the pancreas.
Because insulin release in the human fetal pancreas is unresponsive to glucose stimulation (6), it was important to determine whether this was due to a lack of transcription of the p-cell-specific glucose-sensing apparatus, namely, GLUT-2 and glucokinase. It has been suggested that inappropriate expression levels of these genes may be responsible for the abnormal insulin secretion observed in diabetic rats (31, 32) and in cell lines (8, 33) . In normal p-cells, glucose transport capacity is in excess relative to glucose metabolism. In fact, it has been suggested that glucose transport into the p-cells needs to be reduced by at least 90% to interfere with glucose metabolism (34) , supporting the notion that GLUT-2 plays only a permissive role in glucose sensing. Glucokinase has been proposed to be the p-cell "glucose sensor" (35, 36) because it catalyzes the rate-limiting step in glucose metabolism, which is a prerequisite for insulin secretion. Our RNase protection assay and RT-PCR data indicated the presence of GLUT-1, GLUT-2, and glucokinase transcripts in the 13-wk fetal pancreata, suggesting the presence of the respective functional proteins. Thus, it would appear that fetal p-cells are capable of transporting and phosphorylating glucose. However, we cannot rule out quantitative differences in these processes between the fetal and adult pancreas.
The role of the reg gene and its protein product is unclear in human fetal pancreatic development. The reg protein has been colocalized with insulin within the secretory granules of the regenerating p-cell (37) . Based on these findings, and supported by later work with isolated rat islets (14) , a role has been suggested for the reg gene in pancreatic islet growth and regeneration. However, other investigators have found the gene to be expressed in the exocrine portion of the adult pancreas (12, 15) , where it encodes pancreatic stone protein, a major constituent of the exocrine pancreatic secretion (38) . In the human fetal pancreas, the reg protein has previously been detected in the acinar cells, which were found to be weakly immunoreactive from 16 to 27 wk gestational age, at which point the staining became more intense, and markedly increased at birth (39) . We observed very low expression of the reg gene before 16 wk gestation, at which time a dramatic increase was seen. The levels remained high throughout gestation and reached levels comparable to those in the adult pancreas. Results of our in situ hybridization analysis are in agreement with the results of Miyaura et al. (13) ; that is, reg genes are entirely localized within the acinar tissue and are absent from mesenchymal, ductal, and islet cells. Additionally, reg transcripts did not colocalize with insulin in the fl-cells, unlike the results of Terazono et al. (37) . The barely detectable levels of reg mRNA in the 12-to 14-wk fetal pancreata, which already contain significant levels of the hormone transcripts, suggest that the reg gene does not play a direct role in early islet development. However, the dramatic increase in reg transcripts seen at 16 wk gestation, an age at which there is no significant expansion of the exocrine pancreatic compartment, may implicate the reg gene as being involved in the expansion of the islet mass. This is supported by Francis et al. (14) , who showed an increase in reg mRNA expression associated with adult rat islet cell replication. Although the function of the reg gene product is unknown, prediction of its three-dimensional structure indicates significant homology with plant and animal lectins, suggesting a possible growth-promoting role (40, 41) . Additional work is needed to more clearly define the role of the reg gene in pancreatic development.
The levels of islet hormone transcripts (insulin, glucagon, and somatostatin) increased gradually throughout fetal development. Insulin mRNA levels in the fetal pancreas were found to be 2-to 6-fold lower compared with those in the postnatal pancreas, in contrast to glucagon and somatostatin mRNA levels, which were higher in the fetal than in the postnatal pancreas. These results are in agreement with previously published immunohistochemical and ultrastructural data (1, 3, 4) . The physiologic impact of the relatively high glucagon and somatostatin expression in the fetus is not clear. Transcription levels of the three hormones were similar in the pancreas of the 11-mo-old child and the adult, indicating that islet hormone expression matures completely during the first year of life.
In the normal adult pancreas, amylin is colocalized Figure 6 . Detection of GLUT-2 and glucokinase transcripts using RT-PCR in 13-wk gestational age pancreata. Total RNA (1.3 ~g ) from three different 13-wk pancreata was reverse transcribed into cDNA, aliquots were then amplified as described in Methods, analyzed on agarose gels, and visualized by ethidium bromide staining. Molecular mass markers are a I-kb DNA ladder (BRL, Grand Island, NY), lanes 1 and 15, and a 100-bp ladder (GenSura Laboratories, San Diego, CA), lane 8. GLUT-2 (lanes 2 4 ; 398 bp) and glucokinase (lanes 9-11; 380 bp) transcripts were detected using RT-PCR in three different 13-wk fetal pancreata. Adult islets were used as positive controls for GLUT-2 (lane 5) and glucokinase (lane 12). Adult liver was used as a positive control for GLUT-2 (lane 6) and as a negative control for glucokinase (lane 13), illustrating the specificity of the polymerase chain reaction primers for the islet-specific glucokinase. Water was used as a negative control (lanes 7 and 14). cose stimulus. We first detected amylin mRNA at 13 wk gestation, in agreement with initial amylin immunoreactivity at 13 wk (44), considerably later than insulin immunoreactivity, which occurred at 9 wk gestation. In the previously published immunohistochemical study, the percentage of amylin-positive insulin cells increased with gestational age and reached nearly 100% in the adult pancreas (44) . In accordance with this, we observed an approximately 10-fold increase in amylin transcripts in the adult compared with the fetal pancreas.
The amniotic fluid swallowed by the fetus acts as a stimulus for the developing exocrine pancreas. The nonparallel appearance of secretory proteins in the fetal exocrine pancreas has previously been reported (39, 45, 46) , perhaps reflecting the adaptive ability of the pancreas to the changing composition of the amniotic fluid. Inasmuch as amniotic fluid is devoid of starch, it is not surprising that amylase activity has not been detected in the fetal pancreas (45, 46) . In fact, amylase was not detectable in the neonatal pancreas either (46, 47) , but did increase during the first year (48) . Consistent with this developmental process, we were unable to detect expression of the amylase gene in the fetal pancreas, although high levels of amylase transcripts were detected in the pancreas of the 11-mo-old child and the adult.
In summary, we measured transcriptional expression of various endocrine and exocrine genes in the human pancreas during development. Our results confirmed earlier immunohistochemical and enzymatic studies of the islet hormones, amylin, and amylase. In addition, we showed that the reg gene is developmentally regulated in the human fetal pancreas, with an abrupt increase in expression at 16 wk gestation, and that the gene localizes exclusively to the pancreatic acinar cells. Furthermore, we showed that the GLUT-1, GLUT-2, and glucokinase genes are expressed early in human pancreatic development. This study establishes a baseline of information on the temporal transcriptional regulation of pancreasspecific genes during pancreatic ontogeny and contributes to the basic research and knowledge required before undertaking human fetal tissue transplantation as a means to treat insulin-dependent diabetes.
